Peter Libby and Team Reveal Causal Proteomic Links in Clonal Hematopoiesis
Peter Libby, Mallinckrodt Professor of Medicine and Cardiovascular Specialist at Harvard Medical School and Brigham and Women’s Hospital, posted on LinkedIn:
”Causal Proteomic Consequences of Clonal Hematopoiesis: Integrated Human Genetic and Murine Validation
Zhi Yu, Amelie Vromman…Art Schuermans…Thiago Rentz Ferreira Laginski… Abhishek Niroula…Michael C. Honigberg, Amy E. Lin …Sara Haidermota…Benjamin Ebert…Alexander G. Bick, Siddhartha Jaiswal, Robert E. Gerszten, Peter Libby, Rajat Gupta, Pradeep Natarajan
Presented elegantly today at AHA New Orleans by Zhi Yu, the results of an amazing collaboration on CHIP proteomics that provide new insights and generate novel mechanistic hypotheses regarding the manifold clinical consequences of this newly recognized risk factor.”
Stay updated with Hemostasis Today.
-
Jul 2, 2026, 23:11Michael Makris: Join The Cancer Associated Thrombosis Workshop at ISTH 2026
-
Jul 2, 2026, 21:54Rob Maloney: Rare Disease Requires Relational Care
-
Jul 2, 2026, 21:53Quintijn Bonnez: How ADAMTS13 Conformation May Predict Early Relapse and Guide Pre-Emptive Therapy
-
Jul 2, 2026, 21:52Emina Curic: Improving the Understanding of Factor V Leiden in Everyday Clinical Practice
-
Jul 2, 2026, 21:49Lee Peter Bee: The Plastic in Your Blood Is Sabotaging Your Stem Cells
-
Jul 2, 2026, 21:49Atef Ahmed: The Lethal Triad and Damage Control Philosophy
-
Jul 2, 2026, 20:48João L. Carapinha: How Does HYMPAVZI Simplify Hemophilia Management for Patients?
-
Jul 2, 2026, 20:15Celebrationg The 30 Years Anniversary as The Voice of Stroke in Australia – Stroke Foundation
-
Jul 2, 2026, 19:40Minoo Ahmadinejad: Improving the Recognition of Women and Girls With Hemophilia